These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 28847283)

  • 21. Emergence of exosomal miRNAs as a diagnostic biomarker for Alzheimer's disease.
    Van Giau V; An SS
    J Neurol Sci; 2016 Jan; 360():141-52. PubMed ID: 26723991
    [TBL] [Abstract][Full Text] [Related]  

  • 22. microRNA-132: a key noncoding RNA operating in the cellular phase of Alzheimer's disease.
    Salta E; De Strooper B
    FASEB J; 2017 Feb; 31(2):424-433. PubMed ID: 28148775
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A 9-microRNA Signature in Serum Serves as a Noninvasive Biomarker in Early Diagnosis of Alzheimer's Disease.
    Guo R; Fan G; Zhang J; Wu C; Du Y; Ye H; Li Z; Wang L; Zhang Z; Zhang L; Zhao Y; Lu Z
    J Alzheimers Dis; 2017; 60(4):1365-1377. PubMed ID: 29036818
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA target prediction in glaucoma.
    Romano GL; Platania CB; Forte S; Salomone S; Drago F; Bucolo C
    Prog Brain Res; 2015; 220():217-40. PubMed ID: 26497793
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alzheimer's disease and its treatment by different approaches: A review.
    Srivastava S; Ahmad R; Khare SK
    Eur J Med Chem; 2021 Apr; 216():113320. PubMed ID: 33652356
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unraveling the role of miRNAs in the diagnosis, progression, and therapeutic intervention of Alzheimer's disease.
    Abdelmaksoud NM; Sallam AM; Abulsoud AI; El-Dakroury WA; Abdel Mageed SS; Al-Noshokaty TM; Elrebehy MA; Elshaer SS; Mahmoud NA; Fathi D; Rizk NI; Elballal MS; Mohammed OA; Abdel-Reheim MA; Zaki MB; Saber S; Doghish AS
    Pathol Res Pract; 2024 Jan; 253():155007. PubMed ID: 38061270
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of microRNAs in the pathophysiology of human central nervous system: A focus on neurodegenerative diseases.
    Rezaee D; Saadatpour F; Akbari N; Zoghi A; Najafi S; Beyranvand P; Zamani-Rarani F; Rashidi MA; Bagheri-Mohammadi S; Bakhtiari M
    Ageing Res Rev; 2023 Dec; 92():102090. PubMed ID: 37832609
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of microRNAs in Alzheimer´s disease, type 2 diabetes, and aerobic exercise training.
    De Sousa RAL; Improta-Caria AC
    Metab Brain Dis; 2022 Mar; 37(3):559-580. PubMed ID: 35075500
    [TBL] [Abstract][Full Text] [Related]  

  • 30. microRNA 221 Targets ADAM10 mRNA and is Downregulated in Alzheimer's Disease.
    Manzine PR; Pelucchi S; Horst MA; Vale FAC; Pavarini SCI; Audano M; Mitro N; Di Luca M; Marcello E; Cominetti MR
    J Alzheimers Dis; 2018; 61(1):113-123. PubMed ID: 29036829
    [TBL] [Abstract][Full Text] [Related]  

  • 31. De-repression of FOXO3a death axis by microRNA-132 and -212 causes neuronal apoptosis in Alzheimer's disease.
    Wong HK; Veremeyko T; Patel N; Lemere CA; Walsh DM; Esau C; Vanderburg C; Krichevsky AM
    Hum Mol Genet; 2013 Aug; 22(15):3077-92. PubMed ID: 23585551
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNAs in Alzheimer's disease: differential expression in hippocampus and cell-free cerebrospinal fluid.
    Müller M; Kuiperij HB; Claassen JA; Küsters B; Verbeek MM
    Neurobiol Aging; 2014 Jan; 35(1):152-8. PubMed ID: 23962497
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deregulation of miRNA-181c potentially contributes to the pathogenesis of AD by targeting collapsin response mediator protein 2 in mice.
    Zhou H; Zhang R; Lu K; Yu W; Xie B; Cui D; Jiang L; Zhang Q; Xu S
    J Neurol Sci; 2016 Aug; 367():3-10. PubMed ID: 27423553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dysregulation and diagnostic potential of microRNA in Alzheimer's disease.
    Pan Y; Liu R; Terpstra E; Wang Y; Qiao F; Wang J; Tong Y; Pan B
    J Alzheimers Dis; 2016; 49(1):1-12. PubMed ID: 26484912
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Folic acid deficiency enhances abeta accumulation in APP/PS1 mice brain and decreases amyloid-associated miRNAs expression.
    Liu H; Tian T; Qin S; Li W; Zhang X; Wang X; Gao Y; Huang G
    J Nutr Biochem; 2015 Dec; 26(12):1502-8. PubMed ID: 26345540
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA-146a suppresses ROCK1 allowing hyperphosphorylation of tau in Alzheimer's disease.
    Wang G; Huang Y; Wang LL; Zhang YF; Xu J; Zhou Y; Lourenco GF; Zhang B; Wang Y; Ren RJ; Halliday GM; Chen SD
    Sci Rep; 2016 May; 6():26697. PubMed ID: 27221467
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A single nucleotide polymorphism in primary-microRNA-146a reduces the expression of mature microRNA-146a in patients with Alzheimer's disease and is associated with the pathogenesis of Alzheimer's disease.
    Zhang B; Wang A; Xia C; Lin Q; Chen C
    Mol Med Rep; 2015 Sep; 12(3):4037-4042. PubMed ID: 26095531
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of miRNAs in Neurodegeneration: From Disease Cause to Tools of Biomarker Discovery and Therapeutics.
    Roy B; Lee E; Li T; Rampersaud M
    Genes (Basel); 2022 Feb; 13(3):. PubMed ID: 35327979
    [TBL] [Abstract][Full Text] [Related]  

  • 39. miR-186 is decreased in aged brain and suppresses BACE1 expression.
    Kim J; Yoon H; Chung DE; Brown JL; Belmonte KC; Kim J
    J Neurochem; 2016 May; 137(3):436-45. PubMed ID: 26710318
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Simvastatin ameliorate memory deficits and inflammation in clinical and mouse model of Alzheimer's disease via modulating the expression of miR-106b.
    Huang W; Li Z; Zhao L; Zhao W
    Biomed Pharmacother; 2017 Aug; 92():46-57. PubMed ID: 28528185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.